Lumeda Inc.

Biotechnology ResearchConnecticut, United States2-10 Employees

Lumeda Inc. is a medical technology company advancing photodynamic therapy (PDT) as an adjuvant treatment for patients with non-small cell lung cancer (NSCLC) and other thoracic malignancies.  Lumeda’s breakthrough light dosimetry product called DigiLum™  is designed to activate a photosensitizer drug and deliver PDT  to reduce the recurrence of cancer and enhance antitumor immunity.  DigiLum™ applies advanced photonics and proprietary Artificial Intelligence (AI) software to enable thoracic surgeons to control dosimetry, reduce treatment time and capture data for future treatment planning.

Sign up for free to view info

Email Format Employee directory